A new class of prescription weight-loss medication is transforming the U.S. healthcare system. In his column for the May-June 2024 issue of the Healthcare Journal of Arkansas, ACHI President and CEO Dr. Joe Thompson discusses how drugs such as Ozempic and Wegovy work and why they have become massively popular as a method for weight control. Thompson also looks at areas of concern, including the high cost of the drugs, the lack of evidence on their long-term effects, and the possible need to stay on them for life.
